| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 5.14e-06 | 749 | 20 | 7 | GO:0005509 | |
| Domain | EGF_CA | 2.70e-08 | 86 | 20 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 4.96e-08 | 97 | 20 | 5 | IPR018097 | |
| Domain | EGF_CA | 5.50e-08 | 99 | 20 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.79e-08 | 100 | 20 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.76e-08 | 106 | 20 | 5 | IPR000152 | |
| Domain | EGF_CA | 1.57e-07 | 122 | 20 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-07 | 124 | 20 | 5 | IPR001881 | |
| Domain | EGF | 1.84e-07 | 126 | 20 | 5 | PF00008 | |
| Domain | EGF_3 | 2.30e-07 | 12 | 20 | 3 | PF12947 | |
| Domain | EGF_dom | 2.30e-07 | 12 | 20 | 3 | IPR024731 | |
| Domain | Growth_fac_rcpt_ | 5.34e-07 | 156 | 20 | 5 | IPR009030 | |
| Domain | G2F | 3.27e-06 | 3 | 20 | 2 | SM00682 | |
| Domain | EGF_3 | 4.02e-06 | 235 | 20 | 5 | PS50026 | |
| Domain | EGF | 4.02e-06 | 235 | 20 | 5 | SM00181 | |
| Domain | EGF-like_dom | 5.33e-06 | 249 | 20 | 5 | IPR000742 | |
| Domain | GFP | 6.53e-06 | 4 | 20 | 2 | IPR009017 | |
| Domain | G2F | 6.53e-06 | 4 | 20 | 2 | PF07474 | |
| Domain | G2_nidogen/fibulin_G2F | 6.53e-06 | 4 | 20 | 2 | IPR006605 | |
| Domain | NIDOGEN_G2 | 6.53e-06 | 4 | 20 | 2 | PS50993 | |
| Domain | EGF-like_CS | 6.70e-06 | 261 | 20 | 5 | IPR013032 | |
| Domain | EGF_2 | 7.21e-06 | 265 | 20 | 5 | PS01186 | |
| Domain | NIDO_dom | 1.09e-05 | 5 | 20 | 2 | IPR003886 | |
| Domain | NIDO | 1.09e-05 | 5 | 20 | 2 | PS51220 | |
| Domain | NIDO | 1.09e-05 | 5 | 20 | 2 | SM00539 | |
| Domain | NIDO | 1.09e-05 | 5 | 20 | 2 | PF06119 | |
| Domain | - | 5.96e-05 | 11 | 20 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 5.96e-05 | 11 | 20 | 2 | IPR023413 | |
| Domain | Ldl_recept_b | 9.84e-05 | 14 | 20 | 2 | PF00058 | |
| Domain | LDLRB | 9.84e-05 | 14 | 20 | 2 | PS51120 | |
| Domain | LY | 1.13e-04 | 15 | 20 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.13e-04 | 15 | 20 | 2 | IPR000033 | |
| Domain | EGF_1 | 1.38e-04 | 255 | 20 | 4 | PS00022 | |
| Domain | Thyroglobulin_1 | 1.47e-04 | 17 | 20 | 2 | PF00086 | |
| Domain | TY | 1.47e-04 | 17 | 20 | 2 | SM00211 | |
| Domain | - | 1.47e-04 | 17 | 20 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_1 | 1.47e-04 | 17 | 20 | 2 | PS00484 | |
| Domain | THYROGLOBULIN_1_2 | 1.47e-04 | 17 | 20 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 1.47e-04 | 17 | 20 | 2 | IPR000716 | |
| Domain | Quino_amine_DH_bsu | 2.48e-04 | 22 | 20 | 2 | IPR011044 | |
| Domain | cEGF | 3.49e-04 | 26 | 20 | 2 | IPR026823 | |
| Domain | cEGF | 3.49e-04 | 26 | 20 | 2 | PF12662 | |
| Domain | hEGF | 4.05e-04 | 28 | 20 | 2 | PF12661 | |
| Domain | - | 7.88e-04 | 39 | 20 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.10e-03 | 46 | 20 | 2 | IPR011042 | |
| Domain | EGF_extracell | 1.86e-03 | 60 | 20 | 2 | IPR013111 | |
| Domain | EGF_2 | 1.86e-03 | 60 | 20 | 2 | PF07974 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.06e-04 | 13 | 17 | 2 | M47423 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.42e-04 | 15 | 17 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.31e-04 | 19 | 17 | 2 | MM15594 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.04e-04 | 25 | 17 | 2 | M27879 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.72e-04 | 27 | 17 | 2 | M39545 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.84e-04 | 30 | 17 | 2 | M27216 | |
| Pathway | REACTOME_KERATINIZATION | 7.62e-04 | 153 | 17 | 3 | MM15343 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.88e-04 | 39 | 17 | 2 | MM14604 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.31e-03 | 45 | 17 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.37e-03 | 46 | 17 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.43e-03 | 47 | 17 | 2 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.56e-03 | 49 | 17 | 2 | M618 | |
| Pathway | REACTOME_KERATINIZATION | 2.09e-03 | 217 | 17 | 3 | M27640 | |
| Pathway | PID_NOTCH_PATHWAY | 2.25e-03 | 59 | 17 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.40e-03 | 61 | 17 | 2 | M39540 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 4.30e-03 | 82 | 17 | 2 | MM15922 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.82e-03 | 87 | 17 | 2 | MM15351 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.96e-03 | 97 | 17 | 2 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.44e-03 | 101 | 17 | 2 | M39448 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 8.70e-03 | 118 | 17 | 2 | M39852 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22260998 | ||
| Pubmed | Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice. | 3.14e-07 | 2 | 20 | 2 | 12475645 | |
| Pubmed | Nidogen-1 and nidogen-2 are found in basement membranes during human embryonic development. | 3.14e-07 | 2 | 20 | 2 | 12005023 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17177854 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22623588 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17616934 | ||
| Pubmed | Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. | 3.14e-07 | 2 | 20 | 2 | 17328794 | |
| Pubmed | The absence of nidogen 1 does not affect murine basement membrane formation. | 3.14e-07 | 2 | 20 | 2 | 10958695 | |
| Pubmed | Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture. | 3.14e-07 | 2 | 20 | 2 | 17008882 | |
| Pubmed | Hematopoietic cells are a source of nidogen-1 and nidogen-2 during mouse liver development. | 3.14e-07 | 2 | 20 | 2 | 16618944 | |
| Pubmed | 7.23e-07 | 31 | 20 | 3 | 22274697 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 23681936 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 20819128 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 22691042 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 1.88e-06 | 4 | 20 | 2 | 20040020 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 12243745 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 11493006 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 3.14e-06 | 5 | 20 | 2 | 11006133 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 16899352 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.14e-06 | 5 | 20 | 2 | 15064243 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 23271751 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 21602525 | ||
| Pubmed | Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. | 3.14e-06 | 5 | 20 | 2 | 21670148 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 11733994 | ||
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 4.71e-06 | 6 | 20 | 2 | 10544250 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 11956183 | ||
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 4.71e-06 | 6 | 20 | 2 | 9733643 | |
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 10383933 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 10079256 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 16169548 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 15162516 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 6.59e-06 | 7 | 20 | 2 | 12846471 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 8.78e-06 | 8 | 20 | 2 | 22652674 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 11847210 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 12015298 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 9858718 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 11044610 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 1.13e-05 | 9 | 20 | 2 | 10772929 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 11118901 | ||
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 16245338 | ||
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 1.13e-05 | 9 | 20 | 2 | 22952693 | |
| Pubmed | A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. | 1.13e-05 | 9 | 20 | 2 | 14530295 | |
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 23911870 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.41e-05 | 10 | 20 | 2 | 23665443 | |
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 21084308 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.72e-05 | 11 | 20 | 2 | 17023412 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.72e-05 | 11 | 20 | 2 | 16607638 | |
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 10878608 | ||
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 12866128 | ||
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 16024816 | ||
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.44e-05 | 13 | 20 | 2 | 11578869 | |
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 2.44e-05 | 13 | 20 | 2 | 18356808 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.44e-05 | 13 | 20 | 2 | 31202705 | |
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 28192800 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 2.85e-05 | 14 | 20 | 2 | 20858856 | |
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 14757642 | ||
| Pubmed | Notch3-Jagged signaling controls the pool of undifferentiated airway progenitors. | 2.85e-05 | 14 | 20 | 2 | 25564622 | |
| Pubmed | EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation. | 2.85e-05 | 14 | 20 | 2 | 21949412 | |
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 12971992 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 9291577 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 17194759 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 21307092 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.28e-05 | 15 | 20 | 2 | 15895400 | |
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 3.28e-05 | 15 | 20 | 2 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 3.28e-05 | 15 | 20 | 2 | 16914494 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 16439479 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 10842072 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 15878328 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 3.75e-05 | 16 | 20 | 2 | 27641601 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 32161758 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 3.75e-05 | 16 | 20 | 2 | 12617809 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 17273555 | ||
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 4.25e-05 | 17 | 20 | 2 | 15821257 | |
| Pubmed | Integrin-linked kinase is an adaptor with essential functions during mouse development. | 4.78e-05 | 18 | 20 | 2 | 19829382 | |
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 18093989 | ||
| Pubmed | Lunatic fringe null female mice are infertile due to defects in meiotic maturation. | 4.78e-05 | 18 | 20 | 2 | 15659488 | |
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 12571105 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 15689374 | ||
| Pubmed | 5.34e-05 | 19 | 20 | 2 | 16518823 | ||
| Pubmed | 5.68e-05 | 131 | 20 | 3 | 28634551 | ||
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 21703454 | ||
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 6.55e-05 | 21 | 20 | 2 | 14702043 | |
| Pubmed | 7.21e-05 | 22 | 20 | 2 | 21750033 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 7.89e-05 | 23 | 20 | 2 | 23386589 | |
| Pubmed | 7.89e-05 | 23 | 20 | 2 | 24337118 | ||
| Pubmed | 7.89e-05 | 23 | 20 | 2 | 14701881 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 8.61e-05 | 24 | 20 | 2 | 21420948 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 9.04e-05 | 424 | 20 | 4 | 21731673 | |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 1.01e-04 | 26 | 20 | 2 | 30923192 | |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.01e-04 | 26 | 20 | 2 | 19369401 | |
| Pubmed | 1.26e-04 | 29 | 20 | 2 | 25535917 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.26e-04 | 29 | 20 | 2 | 21402740 | |
| Pubmed | 1.35e-04 | 30 | 20 | 2 | 17257418 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.35e-04 | 30 | 20 | 2 | 24552588 | |
| Pubmed | 1.35e-04 | 30 | 20 | 2 | 19054571 | ||
| Pubmed | 1.35e-04 | 30 | 20 | 2 | 16524929 | ||
| Pubmed | 1.45e-04 | 31 | 20 | 2 | 37573008 | ||
| Cytoband | 6p21.3 | 5.26e-03 | 250 | 20 | 2 | 6p21.3 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.45e-05 | 200 | 20 | 4 | M9549 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 1.98e-05 | 9 | 20 | 2 | M9630 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 5.77e-05 | 15 | 20 | 2 | MM402 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.60e-05 | 16 | 20 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.60e-05 | 16 | 20 | 2 | MM1296 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.92e-04 | 27 | 20 | 2 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.92e-04 | 27 | 20 | 2 | MM1135 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.22e-04 | 29 | 20 | 2 | MM17055 | |
| Coexpression | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY | 2.38e-04 | 30 | 20 | 2 | M10778 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.69e-04 | 795 | 20 | 5 | M39050 | |
| Coexpression | MYC_UP.V1_DN | 2.92e-04 | 172 | 20 | 3 | M2708 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.24e-04 | 35 | 20 | 2 | MM17054 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.24e-04 | 40 | 20 | 2 | M5887 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 4.53e-04 | 200 | 20 | 3 | M9680 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M3068 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.42e-06 | 190 | 20 | 4 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 20 | 4 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 20 | 4 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-06 | 196 | 20 | 4 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.64e-05 | 158 | 20 | 3 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 170 | 20 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 170 | 20 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.86e-05 | 171 | 20 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.97e-05 | 172 | 20 | 3 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.17e-05 | 174 | 20 | 3 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.39e-05 | 176 | 20 | 3 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-05 | 178 | 20 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-05 | 180 | 20 | 3 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.94e-05 | 181 | 20 | 3 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 6.94e-05 | 181 | 20 | 3 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 182 | 20 | 3 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 182 | 20 | 3 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.06e-05 | 182 | 20 | 3 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.06e-05 | 182 | 20 | 3 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 7.17e-05 | 183 | 20 | 3 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.29e-05 | 184 | 20 | 3 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 185 | 20 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-05 | 185 | 20 | 3 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 7.53e-05 | 186 | 20 | 3 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.53e-05 | 186 | 20 | 3 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-05 | 186 | 20 | 3 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 187 | 20 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.77e-05 | 188 | 20 | 3 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.89e-05 | 189 | 20 | 3 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.89e-05 | 189 | 20 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.02e-05 | 190 | 20 | 3 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-05 | 190 | 20 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-05 | 190 | 20 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.02e-05 | 190 | 20 | 3 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.02e-05 | 190 | 20 | 3 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.27e-05 | 192 | 20 | 3 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.27e-05 | 192 | 20 | 3 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.27e-05 | 192 | 20 | 3 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.27e-05 | 192 | 20 | 3 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.40e-05 | 193 | 20 | 3 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.40e-05 | 193 | 20 | 3 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.53e-05 | 194 | 20 | 3 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.53e-05 | 194 | 20 | 3 | b8aa48d7774e4da3351ee2177eb694fcfec7cbc3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.53e-05 | 194 | 20 | 3 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 8.53e-05 | 194 | 20 | 3 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.53e-05 | 194 | 20 | 3 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 195 | 20 | 3 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 195 | 20 | 3 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | cb5860f580b477bfa52b22cdc21b808e1371e6e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.79e-05 | 196 | 20 | 3 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.79e-05 | 196 | 20 | 3 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.79e-05 | 196 | 20 | 3 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.79e-05 | 196 | 20 | 3 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.92e-05 | 197 | 20 | 3 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-05 | 197 | 20 | 3 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 9.06e-05 | 198 | 20 | 3 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_stratified|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 9.06e-05 | 198 | 20 | 3 | b3aec042912ce53bd86e86b6761a0604d9998ab5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.06e-05 | 198 | 20 | 3 | feac39036b5c0ab97b524cc366286942d136d42f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 9.06e-05 | 198 | 20 | 3 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.06e-05 | 198 | 20 | 3 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 9.06e-05 | 198 | 20 | 3 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 9.19e-05 | 199 | 20 | 3 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 9.19e-05 | 199 | 20 | 3 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 9.19e-05 | 199 | 20 | 3 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 9.19e-05 | 199 | 20 | 3 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.19e-05 | 199 | 20 | 3 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 9.19e-05 | 199 | 20 | 3 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.33e-05 | 200 | 20 | 3 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.33e-05 | 200 | 20 | 3 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| Disease | nidogen-2 measurement | 1.87e-06 | 4 | 17 | 2 | EFO_0020608 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.71e-05 | 11 | 17 | 2 | EFO_0801461 | |
| Disease | Carcinoma, Pancreatic Ductal | 8.56e-05 | 24 | 17 | 2 | C0887833 | |
| Disease | Glioblastoma | 9.38e-04 | 79 | 17 | 2 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.06e-03 | 84 | 17 | 2 | C0334588 | |
| Disease | Glioblastoma Multiforme | 1.84e-03 | 111 | 17 | 2 | C1621958 | |
| Disease | creatinine measurement | 2.15e-03 | 995 | 17 | 4 | EFO_0004518 | |
| Disease | Malignant neoplasm of breast | 2.84e-03 | 1074 | 17 | 4 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGFGFGVTIGTLCCF | 591 | Q9NRD9 | |
| PGGNFSCICDSGFTG | 616 | Q9Y219 | |
| GGSSYTCSCLPGFSG | 781 | P14543 | |
| GSFSCTCHGGYTGPS | 831 | Q9UM47 | |
| DGVGSFSCSCLPGFA | 866 | Q9UM47 | |
| CGVPGIGSGFSCAFG | 36 | Q7Z3Y8 | |
| GFPSFSTGGTCDSSC | 56 | Q07627 | |
| VGSPAGSVGCCSFIG | 726 | Q02413 | |
| GGSTFSCACLPGYAG | 871 | Q14112 | |
| CGGELSGATGSFSSP | 1391 | O60494 | |
| GCGTGSSGSACATPV | 1221 | Q14CM0 | |
| FYPGTSGSCSGCGSL | 31 | Q9UBK5 | |
| TAFPCVLGCEGFTSG | 331 | O00635 | |
| FGSSLSAGCRGGCFT | 201 | Q03519 | |
| FAGGCGGTVGAIFTC | 16 | Q9BSK2 | |
| SFSCGGSPGSSAFSL | 86 | Q8IXZ3 | |
| VSGSSTCGFGGPAVS | 721 | Q8N2C7 | |
| EGPVSCCSFSTDGGS | 2061 | Q99973 | |
| SVCFGGSPSSSGSFG | 896 | Q12816 | |
| SICFGGSPCTSTGFG | 916 | Q12816 | |
| SICFDGSPSTGAGFG | 956 | Q12816 | |
| GTLSTSVCFGGSPGT | 1001 | Q12816 | |
| SVCFGGSPGTSVSFG | 1006 | Q12816 | |
| SVCFGGSPSTSAGFG | 1046 | Q12816 | |
| SLCFGGAPSTSLCFG | 1146 | Q12816 | |
| FGATSGCPSLTPGSC | 51 | Q99453 | |
| FGVFGQSCGPSVTSG | 441 | Q2T9J0 |